Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects - Bakker_2021_Drugs.R.D__ |
| Author(s) : Bakker C , van der Aart J , Labots G , Liptrot J , Cross DM , Klaassen ES , Dickinson S , Tasker T , Groeneveld GJ |
| Ref : Drugs R D , : , 2021 |
| Abstract : Bakker_2021_Drugs.R.D__ |
| ESTHER : Bakker_2021_Drugs.R.D__ |
| PubMedSearch : Bakker_2021_Drugs.R.D__ |
| PubMedID: 34164794 |
| Title : Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease - Baakman_2021_Br.J.Clin.Pharmacol__ |
| Author(s) : Baakman AC , Gavan C , van Doeselaar L , de Kam M , Broekhuizen K , Bajenaru O , Camps L , Swart EL , Kalisvaart K , Schoonenboom N , Lemstra E , Scheltens P , Cohen A , van Gerven J , Groeneveld GJ |
| Ref : British Journal of Clinical Pharmacology , : , 2021 |
| Abstract : Baakman_2021_Br.J.Clin.Pharmacol__ |
| ESTHER : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedSearch : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedID: 34964149 |
| Title : Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine - Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| Author(s) : Bakker C , van der Aart J , Hart EP , Klaassen ES , Bergmann KR , van Esdonk MJ , Kay DG , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 6 :e12093 , 2020 |
| Abstract : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| ESTHER : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| PubMedSearch : Bakker_2020_Alzheimers.Dement.(N.Y)_6_e12093 |
| PubMedID: 33083515 |
| Title : No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model - Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| Author(s) : Baakman AC , Alvarez-Jimenez R , Loewen G , de Kam ML , Broekhuizen K , Hilt DC , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 5 :89 , 2019 |
| Abstract : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| ESTHER : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| PubMedSearch : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| PubMedID: 30984817 |
| Title : First in human study with a prodrug of galantamine: Improved benefit-risk ratio? - Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| Author(s) : Baakman AC , t Hart E , Kay DG , Stevens J , Klaassen ES , Maelicke A , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 2 :13 , 2016 |
| Abstract : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| ESTHER : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedSearch : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedID: 29067291 |
| Title : [Fever, large eyes and confusion\; the anticholinergic syndrome] - Jellema_2002_Ned.Tijdschr.Geneeskd_146_2173 |
| Author(s) : Jellema K , Groeneveld GJ , van Gijn J |
| Ref : Ned Tijdschr Geneeskd , 146 :2173 , 2002 |
| Abstract : Jellema_2002_Ned.Tijdschr.Geneeskd_146_2173 |
| ESTHER : Jellema_2002_Ned.Tijdschr.Geneeskd_146_2173 |
| PubMedSearch : Jellema_2002_Ned.Tijdschr.Geneeskd_146_2173 |
| PubMedID: 12467156 |